On February 25, 2023, the conference on the 2022 Top Ten Chinese Medicine Academic Advances sponsored by Chinese Medical Association was held in Beijing during which the research result of Professor Yang Wenming's team of the First Affiliated Hospital of Anhui University of Chinese Medicine, "Shufeng Jiedu Capsule for the treatment of Covid-19 infection" was successfully selected.
Traditional Chinese medicine has a long history of fighting epidemics. After thousands of years of clinical practice, it has accumulated rich experience in fighting epidemics, and played an irreplaceable role in the battle against COVID-19.
The team of Professor Yang Wenming found that the traditional Chinese medicine Shufeng Jiedu capsule can significantly improve the clinical symptoms of COVID-19 infected Omicron variant strain, effectively shorten the duration of symptoms, reduce the weight conversion rate, improve the cure rate, and shorten the negative nucleic acid time through a randomized controlled study.
It is reported that from 2020, the Chinese Society of Traditional Chinese Medicine will release the annual "Top Ten Traditional Chinese Medicine Academic Advances" every year, which has caused great repercussions in the industry. The 2022 selection work adheres to the "four aspects", breaks the "four aspects", highlights the solution of clinical problems, answers scientific questions, leads the development of the industry, reflects the exploratory and forward-looking, innovative and breakthrough, and focuses on the new laws, new discoveries, new methods, new products, and new theories obtained in the basic research and applied basic Chinese medicine research.
